Cancer drug set for NHS fast-track
Friday 24 December 2010
A new drug to treat advanced kidney cancer has been fast-tracked for use on the NHS, a health watchdog said yesterday.
The National Institute for Health and Clinical Excellence (Nice) is recommending Votrient (pazopanib). Pharmaceutical giant GlaxoSmithKline has agreed to a 12.5 per discount to the NHS, following the outcome of a clinical trial, comparing the drug with Sutent (sunitinib), which is already approved.
Dr Carole Longson, from Nice, said: "Pazopanib will offer patients an additional option and, for some, a more favourable side-effect profile."
Each year more than 8,000 new cases of kidney cancer are diagnosed in the UK, and almost half will lead to death.
Life & Style blogs
Holocaust Memorial Day: 70 years since Auschwitz liberation, these are the stories of survivors
Double chins could be 'cured' without surgery or dieting using new injection
Does the path to true love really lie in these 36 questions?
Hershey's angers US chocolate purists by forcing company to stop importing 'yummy' Cadbury bars
Pot of gold: tasting the world’s most expensive tea
- 1 The BBC has just done more to eradicate ‘terrorism’ than all our wars since 9/11
- 2 Does the path to true love really lie in these 36 questions?
- 3 Saudi preacher who 'raped and tortured' his five -year-old daughter to death is released after paying 'blood money'
- 4 Presidential optical illusion offers clues to how brain processes faces
- 5 Roald Dahl letter warning student to 'eschew beastly adjectives' rediscovered after 35 years
£25000 - £40000 per annum: Recruitment Genius: This web-based lead generation ...
£125 - £150 per day + Negotiable: Tradewind Recruitment: A 'wonderful primary ...
£90 - £140 per day: Tradewind Recruitment: Our client is an 11-16 mixed commun...
£32000 - £36000 per annum: Recruitment Genius: A rapidly developing company in...